Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, CorMedix Inc (NASDAQ: CRMD) closed at $10.27 down -6.38% from its previous closing price of $10.97. In other words, the price has decreased by -$6.38 from its previous closing price. On the day, 1.39 million shares were traded. CRMD stock price reached its highest trading level at $11.25 during the session, while it also had its lowest trading level at $10.25.
Ratios:
For a deeper understanding of CorMedix Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.96. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on January 13, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
On August 26, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $13.
On August 10, 2023, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $6.RBC Capital Mkts initiated its Outperform rating on August 10, 2023, with a $6 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 31 ’24 when Mistry Erin bought 1,500 shares for $9.99 per share. The transaction valued at 14,985 led to the insider holds 52,011 shares of the business.
Hurlburt Elizabeth sold 140,027 shares of CRMD for $1,565,670 on Nov 14 ’24. The EVP now owns 45,397 shares after completing the transaction at $11.18 per share. On Nov 14 ’24, another insider, Hurlburt Elizabeth, who serves as the Officer of the company, bought 140,027 shares for $11.12 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRMD now has a Market Capitalization of 623154880 and an Enterprise Value of 577681792. For the stock, the TTM Price-to-Sale (P/S) ratio is 50.83 while its Price-to-Book (P/B) ratio in mrq is 10.13. Its current Enterprise Value per Revenue stands at 47.111 whereas that against EBITDA is -11.379.
Stock Price History:
The Beta on a monthly basis for CRMD is 1.59, which has changed by 2.4463086 over the last 52 weeks, in comparison to a change of 0.22208416 over the same period for the S&P500. Over the past 52 weeks, CRMD has reached a high of $13.85, while it has fallen to a 52-week low of $2.89. The 50-Day Moving Average of the stock is 2.52%, while the 200-Day Moving Average is calculated to be 39.35%.
Shares Statistics:
For the past three months, CRMD has traded an average of 1.18M shares per day and 1293050 over the past ten days. A total of 60.68M shares are outstanding, with a floating share count of 59.25M. Insiders hold about 2.35% of the company’s shares, while institutions hold 32.01% stake in the company. Shares short for CRMD as of 1736899200 were 7083149 with a Short Ratio of 6.02, compared to 1734048000 on 6728207. Therefore, it implies a Short% of Shares Outstanding of 7083149 and a Short% of Float of 11.690000000000001.
